Trial Profile
A retrospective study to investigate efficacy and safety of brentuximab vedotin in adult patients with relapsed CD30-positive lymphomas.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Anaplastic large cell lymphoma; Hodgkin's disease; Lymphoma
- Focus Therapeutic Use
- 05 Dec 2015 New trial record